Stocks Health care ICUI
NASDAQ · Health careIcu Medical Inc (ICUI)
Icu Medical Inc brought in $2.2B of revenue over the twelve months to September 30, 2026, down 5.9% from a year earlier. Net income was $60.3M, a net margin of 2.8%. Operating cash flow minus capital spending left $91.8M of free cash flow in fiscal 2025. At September 30, 2026 it held $301.8M in cash against $1.2B of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on November 5, 2026.
Key facts about Icu Medical Inc
- Net worth
- Icu Medical Inc has a market value (market cap) of $4.5B at the latest share price, and shareholders' equity of $2.2B on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $2.2B (-6.3% year on year), with net income of $732K. Over the 12 months to September 30, 2026: revenue $2.2B, net income $60.3M.
- Cash flow
- In fiscal 2025 operations brought in $179.8M of cash; after $88M of capital spending, free cash flow was $91.8M.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on November 5, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
- Next earnings report
- Icu Medical Inc's next report is expected around February 18, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
What Icu Medical Inc does
Icu Medical Inc is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker ICUI.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $2.2B | $732K | $0.03 | $91.8M |
| 2024 | $2.4B | -$117.7M | -$4.83 | $124.7M |
| 2023 | $2.3B | -$29.7M | -$1.23 | $82.3M |
| 2022 | $2.3B | -$74.3M | -$3.11 | -$152.4M |
| 2021 | $1.3B | $103.1M | $4.74 | $199M |
| 2020 | $1.3B | $86.9M | $4.02 | $130.7M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where ICUI ranks in Health care
Latest SEC filings
What Icu Medical Inc has filed recently, newest first. Each links to the original document on SEC EDGAR.
- November 5, 2026Quarterly report 10-Q · period to September 30, 2026Revenue rose 4.4% to $560.4M versus the same quarter last year; diluted EPS $1.07 versus -$0.14.
- November 5, 2026
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- August 13, 2026Passive stake changed SCHEDULE 13G/A
- August 6, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 0.5% to $551.7M versus the same quarter last year; diluted EPS $0.76 versus $1.43.
- August 6, 2026
- June 1, 2026
- May 18, 2026
- May 13, 2026Passive stake changed SCHEDULE 13G/A
- May 7, 2026Quarterly report 10-Q · period to March 31, 2026Revenue fell 12% to $530.2M versus the same quarter last year; diluted EPS $1.20 versus -$0.63.
What is ICUI worth? A DCF from its reported cash flow
Insider trades
What the people running Icu Medical Inc did with its shares, from the Form 4 filings they must send the SEC within two business days.
Insiders sold $4.5M worth of shares in the last 90 days and bought none on the open market. Most of the selling (78%) was pre-planned under Rule 10b5-1 trading plans.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| September 3, 2026 | Sanzone Virginia RuthVP, General Counsel | Soldpre-planned (10b5-1) | 2,202 | $369.2K |
| September 3, 2026 | Sanzone Virginia RuthVP, General Counsel | Soldpre-planned (10b5-1) | 1,238 | $208.5K |
| September 3, 2026 | Sanzone Virginia RuthVP, General Counsel | Soldpre-planned (10b5-1) | 724 | $122.7K |
| September 3, 2026 | Sanzone Virginia RuthVP, General Counsel | Soldpre-planned (10b5-1) | 692 | $118.7K |
| September 1, 2026 | Bonnell Brian MichaelChief Financial Officer | Soldpre-planned (10b5-1) | 6,381 | $1.1M |
| August 31, 2026 | Bonnell Brian MichaelChief Financial Officer | Soldpre-planned (10b5-1) | 1,712 | $292.8K |
| August 31, 2026 | Bonnell Brian MichaelChief Financial Officer | Soldpre-planned (10b5-1) | 1,914 | $329.4K |
| August 31, 2026 | Bonnell Brian MichaelChief Financial Officer | Soldpre-planned (10b5-1) | 4,568 | $792.3K |
Who owns ICUI
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| JANUS HENDERSON GROUP Ltd.13G, passive | 11.1% | August 13, 2026 |
| Vanguard Portfolio Management13G, passive | 5.82% | April 29, 2026 |
| Fuller & Thaler Asset Management, Inc.13G, passive | 5.19% | August 14, 2026 |
| Vanguard Capital Management13G, passive | 5.19% | April 30, 2026 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 288 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| BlackRock, Inc. | 3,753,409 | +145,087 |
| Jupiter Topco LLC | 2,781,620 | new |
| Vanguard Portfolio Management LLC | 1,470,583 | +32,907 |
| Fuller & Thaler Asset Management, Inc. | 1,298,127 | +77,588 |
| Vanguard Capital Management LLC | 1,123,237 | +11,362 |
| Dimensional Fund Advisors LP | 1,053,476 | +69,674 |
| State Street Corp | 1,024,369 | +56,316 |
| Schroder Investment Management Group | 739,138 | +37,858 |
| Ameriprise Financial Inc | 689,573 | +83,845 |
| Geode Capital Management, LLC | 660,423 | +49,204 |
| River Road Asset Management, LLC | 626,290 | -20,140 |
| Citadel Advisors LLC | 536,225 | +202,889 |
| Neuberger Berman Group LLC | 451,279 | +4,860 |
| Jpmorgan Chase & Co | 440,468 | -27,349 |
| Goldman Sachs Group Inc | 417,342 | +94,651 |
| Morgan Stanley | 372,583 | -154,259 |
| Bank of America Corp | 368,754 | +37,015 |
| Toronto Dominion Bank | 358,023 | +149,091 |
| Charles Schwab Investment Management Inc | 331,052 | +8,573 |
| Nomura Asset Management International Inc. | 328,969 | +34,650 |
Insiders
12 insiders reported holding 290,508 shares in total, about $52.4M at the last price.
| Holder | Shares |
|---|---|
| Jain VivekChairman and CEO, Director | 126,833 |
| Bonnell Brian MichaelChief Financial Officer | 56,062 |
| Voigtlander Christian B.Chief Operating Officer | 37,377 |
| Woolson DanielVP, GM-Infusion Capital | 17,062 |
| Sanzone Virginia RuthVP, General Counsel | 14,604 |
| Greenberg David C.Director | 9,214 |
| Abbey DonaldDirector | 6,004 |
| Hoffmeister David FDirector | 6,004 |
| Finney Elisha WDirector | 4,871 |
| Hernandez LaurieDirector | 4,862 |
Questions about ICUI
What does Icu Medical Inc do?
Icu Medical Inc is a company in the Health care sector, listed on NASDAQ as ICUI. Its shares trade on NASDAQ under the ticker ICUI.
What is Icu Medical Inc's net worth?
Icu Medical Inc has a market value (market cap) of $4.5B at the latest share price, and shareholders' equity of $2.2B on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Icu Medical Inc profitable?
Yes. Over the twelve months to September 30, 2026 it reported net income of $60.3M on revenue of $2.2B, a net margin of 2.8%.
How much revenue does Icu Medical Inc make?
Over the twelve months to September 30, 2026 Icu Medical Inc reported revenue of $2.2B. That is 5.9% less than a year earlier.
When did Icu Medical Inc last report?
Its most recent periodic report is the quarterly report (10-Q) filed on November 5, 2026. It covers the period to September 30, 2026.
When is Icu Medical Inc's next earnings report?
Icu Medical Inc's next report is expected around February 18, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare ICUI with
Follow ICUI
Get an email when Icu Medical Inc files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Icu Medical Inc tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.